Skip to content
Screener

MiNK Therapeutics, Inc. INKT Q1 2026 Annual earnings

Reported May 15, 2026 · Before market open

EPS-$0.57Beat by $0.20
EPS estimate-$0.77

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.6M
EPS estimate-$0.35

FAQ

When did MiNK Therapeutics, Inc. report Q1 2026 earnings?
MiNK Therapeutics, Inc. (INKT) reported Q1 2026 earnings on May 15, 2026 before market open.
What were MiNK Therapeutics, Inc.'s Q1 2026 revenue and EPS?
MiNK Therapeutics, Inc. reported eps of $-0.57 for Q1 2026.
Did MiNK Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.77 by $0.20.
How did MiNK Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 18.6% from $-0.70.
Where can I find MiNK Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-225369) and the 10-K periodic report (0001193125-26-134813) directly on SEC EDGAR. The filing index links above go to sec.gov.